Title : A novel targeted immunotherapy for CTCL is on its way: Anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studies.

Pub. Date : 2015 Sep

PMID : 26405593






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A novel targeted immunotherapy for CTCL is on its way: Anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studies. iph4102 TSPY like 2 Homo sapiens